alexa Prevention Of Atypical Antipsychotics-induced Weight Gain: Efficacy And Mechanism Of Berberine Treatment | 14809
ISSN: 2165-7904

Journal of Obesity & Weight Loss Therapy
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

2nd International Conference and Exhibition on Obesity & Weight Management

Yueshan Hu
ScientificTracks Abstracts: J Obes Weight Loss Ther
DOI: 10.4172/2165-7904.S1.010
Abstract
Second generation antipsychotics (atypical) have become the first line medications for schizophrenia therapy. However, the use of atypical antipsychotics (such as olanzapine and clozapine) is associated with serious metabolic adverse effects including weight gain. So far tremendous efforts have been put forth for development of adjunctive medications to attenuate the weight gain induced by antipsychotics. However, a recent review of clinical trial results has concluded that no adjunctive medication was recommended for broad clinical use. Berberine, a herbal alkaloid, has been reported to present multiple pharmacological effects, such as anti-microbial, anti-cancer, anti-inflammation, anti-obesity, anti-diabetes, and protective effect on schizophrenia. We have performed a series of studies and demonstrated that berberine intervention significantly prevents fat accumulation in cultured mouse adipocytes, in human adipocytes, in a diet-induced-obesity mouse model, and in obese human subjects. Subsequently, we have shown that the addition of berberine completely prevented clozapine induced fat accumulation in cultured mouse adipocytes. Utilizing a well-replicated rat model of olanzapine-induced weight gain, we have recently shown that two weeks of berberine treatment significantly prevented olanzapine-induced weight gain and white fat accumulation. A significant loss of brown fat caused by olanzapine treatment has also been prevented by the addition of berberine. In addition, the weight gain prevention efficacy of berberine treatment was associated with changes in the expression of multiple key genes controlling energy expenditure. Our berberine studies provide valuable scientific knowledge for future drug development geared toward preventing the metabolic side effects and increasing compliance of atypical antipsychotics.
Biography
Yueshan Hu was a medical doctor of Integrated Traditional Chinese & Western Medicine in China, and obtained his Ph.D. of Pharmaceutical Sciences in USA. Currently, he works as a Research Scientist at Avera McKennan Hospital & University Health Center, and an assistant Professor at University of South Dakota, Department of Psychiatry. With more than five senior-authored publications in obesity field (among 20+ papers), he was honored to be a fellow of The Obesity Society. In addition, he was selected to be an editorial board member of Phytopharmacology, due to his outstanding work in phytomedicine area.
image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
Leave Your Message 24x7